Yutaro Soejima
Overview
Explore the profile of Yutaro Soejima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ichikawa K, Adachi S, Takase-Minegishi K, Nakayama Y, Nagasawa Y, Iizuka Y, et al.
Clin Exp Rheumatol
. 2025 Feb;
PMID: 39907597
Objectives: To characterise patients with trisomy 8 presenting with autoinflammatory features, comparing them to patients with Behçet's disease (BD). Methods: We comprehensively reviewed studies on trisomy 8-associated autoinflammatory symptoms from...
2.
Hirahara L, Kirino Y, Soejima Y, Iizuka Y, Yoshimi R, Fujieda Y, et al.
Front Immunol
. 2024 Apr;
15:1354969.
PMID: 38686380
Background: Little is known about the relationship between the disease activity of Behçet disease (BD) and the incidence of inflammatory major organ events. Objectives: In this prospective registry study, we...
3.
Hidekawa C, Yoshimi R, Saigusa Y, Tamura J, Kojitani N, Suzuki N, et al.
Front Immunol
. 2023 Sep;
14:1227403.
PMID: 37720209
Objectives: Infection is a leading cause of death in patients with systemic lupus erythematosus (SLE). Alt hough hydroxychloroquine (HCQ) has been reported to inhibit infection, evidence from Asian populations remains...
4.
Teshigawara T, Meguro A, Takeuchi M, Ishido M, Soejima Y, Hirahara L, et al.
Ocul Immunol Inflamm
. 2023 May;
32(4):447-453.
PMID: 37133403
Purpose: To investigate whether polymorphisms of and , which each encode protein ligands for a family of tyrosine kinase receptors, are associated with Behçet's disease (BD) in a Japanese population....
5.
Samukawa S, Yoshimi R, Kojitani N, Uzawa Y, Takase-Minegishi K, Kirino Y, et al.
J Infect Chemother
. 2022 Nov;
29(3):347-352.
PMID: 36384196
Cryptococcal meningitis (CM) is a life-threatening disease that primarily affects patients with human immunodeficiency virus (HIV). Antifungal therapy with antiretroviral treatment (ART) usually leads to the clinical remission of CM;...
6.
Hirahara L, Takase-Minegishi K, Kirino Y, Iizuka-Iribe Y, Soejima Y, Yoshimi R, et al.
Front Immunol
. 2022 Apr;
13:852297.
PMID: 35359926
Behçet's disease (BD) is a systemic inflammatory disease characterized by recurrent oral ulcers, genital ulcers, cutaneous inflammation, and uveitis. In addition, other potentially life-threatening lesions may occur in the intestinal...
7.
Hidekawa C, Yoshimi R, Kishimoto D, Kato H, Mitsuhashi M, Sakurai N, et al.
Intern Med
. 2022 Jan;
61(15):2377-2385.
PMID: 35022342
Disseminated nontuberculous mycobacterial infection (DNTM) is typically observed in immunocompromised hosts. Recently, it has been reported that healthy individuals with serum neutralizing autoantibodies for interferon (IFN)-γ can also develop DNTM....
8.
Iizuka Y, Takase-Minegishi K, Hirahara L, Kirino Y, Soejima Y, Namkoong H, et al.
Mod Rheumatol
. 2021 Nov;
32(6):1153-1162.
PMID: 34752620
Objectives: This study aimed to determine the clinical efficacy of apremilast for oral ulcers (OUs), extra-oral manifestations, and overall disease activity in patients with Behçet's disease (BD). Methods: A systematic...
9.
Soejima Y, Kirino Y, Takeno M, Kurosawa M, Takeuchi M, Yoshimi R, et al.
Arthritis Res Ther
. 2021 Feb;
23(1):49.
PMID: 33522943
Background: We hypothesized that Behçet's disease (BD) consists of several clinical subtypes with different severity, resulting in heterogeneity of the disease. Here, we conducted a study to identify clinical clusters...
10.
Hirahara L, Kirino Y, Soejima Y, Takeno M, Takase-Minegishi K, Yoshimi R, et al.
Mod Rheumatol
. 2020 Sep;
31(4):856-861.
PMID: 32996801
Objective: To determine the real-world short-term efficacy and safety of apremilast for Behçet's disease (BD). Methods: The study included patients who received apremilast for refractory oral ulcers in addition to...